Pay in 4 interest-free payments of $7.24 Learn more
Ships within 48 hours · Estimated delivery Jul 31 - Aug 5
S., and Kaufman, R
- Never expose to temperatures above 25 C for extended periods
Jiangsu Hengrui Pharmaceuticals and Kailera Therapeutics report positive topline data from 8 mg dose of phase 2 obesity trial of GLP-1/GIP receptor dual agonist HRS9531
Though anecdotal reports are common, large-scale human trials remain limited, highlighting the need for further scientific validation
Price unavailable In vitro research use only Not for human or animal use metabolic Best SellerOut of Stock GLP-2 TZ Tirzepatide (GLP-2 TZ) is a dual GIP/GLP-1 receptor agonist research peptide studied extensively in incretin receptor pharmacology and metabolic signaling research
US$ 29.11
US$ 20.01
US$ 22.44
US$ 25.82
:max_bytes(150000):strip_icc()/health-GettyImages-2025836701-ce3f5ccf0f98428e9d14abaeb07ba307.jpg)
US$ 29.19
US$ 28.29
